Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
LIDR - AEye Inc - Stock Price Chart
TickerLIDR [NASD]
CompanyAEye Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap16.77MEPS (ttm)-14.71
P/E-EPS this Y29.10%
Forward P/E-EPS next Y-0.67%
PEG-EPS past 5Y-657.36%
P/S11.49EPS next 5Y-
P/B0.56EPS Q/Q-2913.92%
Dividend-Sales Q/Q-93.68%
Insider Own9.59%Inst Own13.18%
Insider Trans-58.86%Inst Trans-
Short Float3.62%EarningsMay 14/a
Analyst Recom3.00Target Price1.20
Avg Volume333.55K52W Range0.92 - 24.00
May-10-24 08:17AM Why Is AEye (LIDR) Stock Up 38% Today? (InvestorPlace) +115.00%
07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
May-09-24 05:00PM AEye Announces Partnership with Leading Automotive Electronics and Vision Solutions Provider, LITEON (Business Wire)
Apr-24-24 08:55AM AudioEye, Inc. (NASDAQ:AEYE) Q1 2024 Earnings Call Transcript (Insider Monkey) -6.07%
Apr-23-24 08:55PM AEYE Stock Earnings: AudioEye Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +9.28%
08:15AM AEye to Report First Quarter 2024 Financial Results on Tuesday, May 14 (Business Wire)
Mar-27-24 10:13AM AEye, Inc. (NASDAQ:LIDR) Q4 2023 Earnings Call Transcript (Insider Monkey) -19.11%
Mar-26-24 08:53PM LIDR Stock Earnings: AEye Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -9.25%
04:05PM AEye Reports Fourth Quarter 2023 Results (Business Wire)
04:01PM AEye Introduces Apollo the First Product in the 4Sight Flex Family (Business Wire)
OKLO - Oklo Inc. - Stock Price Chart
TickerOKLO [NYSE]
CompanyOklo Inc.
CountryUSA
IndustryShell Companies
Market Cap364.19MEPS (ttm)0.19
P/E45.19EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.23EPS Q/Q-26.50%
Dividend-Sales Q/Q-
Insider Own32.37%Inst Own59.48%
Insider Trans0.00%Inst Trans0.84%
Short Float0.41%Earnings-
Analyst Recom-Target Price-
Avg Volume971.22K52W Range10.27 - 18.80
May-10-24 07:52AM Oklo Inc. Begins Trading on the New York Stock Exchange (Business Wire) -53.65%
May-07-24 04:34PM AltC Acquisition Corp. Stockholders Approve Business Combination with Oklo (PR Newswire)
Apr-25-24 08:03PM Special Meeting of AltC Acquisition Corp. Stockholders to Approve Business Combination with Oklo Scheduled for May 7, 2024 (PR Newswire)
Apr-08-24 08:32AM Oklo Signs LOI to Supply 50 Megawatts of Power to Diamondback Energy (Business Wire) +22.52%
Apr-04-24 03:10PM Altman-Backed SPAC Thats Targeting Nuclear Firm Has Surged 22% (Bloomberg)
Jan-19-24 05:40PM ADDING and REPLACING Oklo to Host Investor Day on Friday, February 2, 2024 (Business Wire)
Dec-19-23 08:47AM Oklo Names Siemens Energy as Preferred Supplier in MOU on Advanced Fission Power Plant Deployments (Business Wire)
Oct-12-23 07:00AM Super Investor Sam Altmans Interests Collide in a Nuclear Merger (The Wall Street Journal)
Oct-05-23 05:11PM AltC Acquisition Corp. Announces Stockholder Approval of Extension Amendment Proposal at Special Meeting and Extends the Redemption Reversal Deadline (PR Newswire)
Sep-27-23 05:43PM AltC Acquisition Corp. and Oklo Announce Filing of Registration Statement on Form S-4 in Connection with Proposed Business Combination (PR Newswire)
XPOF - Xponential Fitness Inc - Stock Price Chart
TickerXPOF [NYSE, RUT]
CompanyXponential Fitness Inc
CountryUSA
IndustryLeisure
Market Cap267.80MEPS (ttm)0.06
P/E134.39EPS this Y216.99%
Forward P/E5.59EPS next Y71.05%
PEG2.97EPS past 5Y-
P/S0.82EPS next 5Y45.30%
P/B-EPS Q/Q78.14%
Dividend-Sales Q/Q12.49%
Insider Own28.18%Inst Own75.10%
Insider Trans-1.15%Inst Trans3.07%
Short Float17.50%EarningsMay 02/a
Analyst Recom1.46Target Price25.08
Avg Volume761.43K52W Range8.30 - 29.69
May-10-24 03:51PM Xponential Fitness Suspends CEO Amid Federal Probe, Shares Plunge (MT Newswires) -31.45%
03:41PM Xponential Fitness Suspends CEO Geisler, Discloses Investigation (Bloomberg)
03:02PM Xponential Fitness Appoints Brenda Morris as Interim CEO (Business Wire)
May-06-24 10:28AM Xponential Fitness, Inc. (NYSE:XPOF) Q1 2024 Earnings Call Transcript (Insider Monkey) +5.55%
May-03-24 08:30PM Xponential Fitness (XPOF) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) -14.15%
10:38AM B. Riley Adjusts Xponential Fitness Price Target to $31 From $28, Maintains Buy Rating (MT Newswires)
09:30AM Xponential Fitness (XPOF) Q1 2024 Earnings Call Transcript (Motley Fool)
May-02-24 08:57PM XPOF Stock Earnings: Xponential Fitness Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:49PM What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks (InvestorPlace)
06:15PM Xponential Fitness (XPOF) Q1 Earnings Miss Estimates (Zacks)
AEMD - Aethlon Medical Inc - Stock Price Chart
TickerAEMD [NASD]
CompanyAethlon Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap3.10MEPS (ttm)-5.02
P/E-EPS this Y11.53%
Forward P/E-EPS next Y49.62%
PEG-EPS past 5Y38.94%
P/S5.44EPS next 5Y-
P/B0.40EPS Q/Q-10.91%
Dividend-Sales Q/Q-
Insider Own13.01%Inst Own1.98%
Insider Trans0.00%Inst Trans-
Short Float3.04%EarningsFeb 14/a
Analyst Recom2.00Target Price23.00
Avg Volume8.77K52W Range1.16 - 5.00
May-10-24 08:01AM Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles From Cancer Patient Plasma (PR Newswire)
Feb-21-24 08:01AM Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices (PR Newswire)
Feb-15-24 10:03AM Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript (Insider Monkey) -5.20%
Feb-14-24 04:15PM Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update (PR Newswire)
Feb-07-24 08:00AM Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 (PR Newswire)
Nov-16-23 09:35AM Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2024 Earnings Call Transcript (Insider Monkey)
Nov-14-23 04:15PM Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update (PR Newswire)
Nov-13-23 08:01AM Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (PR Newswire)
Nov-06-23 08:01AM Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023 (PR Newswire)
Oct-12-23 10:19AM AEMD: Authorization to Conduct Study in India Moves Oncology Initiatives Ahead (Zacks)
MGNX - Macrogenics Inc - Stock Price Chart
TickerMGNX [NASD, RUT]
CompanyMacrogenics Inc
CountryUSA
IndustryBiotechnology
Market Cap207.07MEPS (ttm)-0.38
P/E-EPS this Y-1832.24%
Forward P/E-EPS next Y40.46%
PEG-EPS past 5Y48.88%
P/S4.78EPS next 5Y-
P/B1.95EPS Q/Q-36.25%
Dividend-Sales Q/Q-62.83%
Insider Own6.45%Inst Own95.87%
Insider Trans-6.78%Inst Trans-8.39%
Short Float17.03%EarningsMay 09/a
Analyst Recom1.75Target Price15.10
Avg Volume1.48M52W Range4.29 - 21.88
May-10-24Downgrade TD Cowen Buy → Hold
May-10-24Downgrade Stifel Buy → Hold $29 → $7
May-10-24Downgrade BMO Capital Markets Outperform → Market Perform $24 → $8
May-10-24 06:01PM MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study Hagens Berman (GlobeNewswire) -77.44%
04:51PM Macrogenics Stock Drops 77% After Study Deaths (The Wall Street Journal)
03:29PM Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical ... (GuruFocus.com)
03:17PM MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:01PM Top Midday Decliners (MT Newswires)
08:35AM Why Is Macrogenics (MGNX) Stock Down 69% Today? (InvestorPlace)
07:48AM Top Premarket Decliners (MT Newswires)
07:30AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
07:15AM BMO Downgrades MacroGenics to Market Perform From Outperform, Price Target at $8 (MT Newswires)
07:14AM Stifel Downgrades MacroGenics to Hold (MT Newswires)
BFRI - Biofrontera Inc - Stock Price Chart
TickerBFRI [NASD]
CompanyBiofrontera Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap6.41MEPS (ttm)-15.82
P/E-EPS this Y75.08%
Forward P/E-EPS next Y83.20%
PEG-EPS past 5Y7.90%
P/S0.19EPS next 5Y-
P/B0.40EPS Q/Q178.97%
Dividend-Sales Q/Q4.46%
Insider Own37.89%Inst Own24.29%
Insider Trans0.00%Inst Trans-
Short Float0.75%EarningsMar 15/a
Analyst Recom1.00Target Price16.00
Avg Volume616.95K52W Range0.61 - 13.42
May-06-24 10:30AM Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024 (ACCESSWIRE)
May-03-24 08:50AM Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants (ACCESSWIRE)
Mar-26-24 04:30PM Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals (ACCESSWIRE) -5.45%
Mar-19-24 09:22AM Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript (Insider Monkey) -6.35%
Mar-15-24 09:52PM BFRI Stock Earnings: Biofrontera Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -11.43%
08:25PM CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update (ACCESSWIRE)
06:10PM Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update (ACCESSWIRE)
Mar-08-24 09:00AM Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024 (ACCESSWIRE)
Feb-23-24 08:40AM Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules (ACCESSWIRE) -7.54%
Feb-20-24 08:10AM Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG (ACCESSWIRE) +53.44%
AEHL - Antelope Enterprise Holdings Ltd - Stock Price Chart
TickerAEHL [NASD]
CompanyAntelope Enterprise Holdings Ltd
CountryChina
IndustryBuilding Products & Equipment
Market Cap9.44MEPS (ttm)-3.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y38.52%
P/S0.14EPS next 5Y-
P/B2.57EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own42.61%Inst Own0.52%
Insider Trans0.00%Inst Trans180.47%
Short Float4.64%EarningsMay 07/b
Analyst Recom-Target Price-
Avg Volume238.23K52W Range1.22 - 16.40
May-10-24 07:00AM Antelope Enterprise Announces Second Half and Full Year 2023 Financial Results (GlobeNewswire)
May-09-24 08:30AM Antelope Enterprise Announces Second Half and Fiscal Year End 2023 Earnings Conference Call (GlobeNewswire)
May-07-24 07:00AM Antelope Enterprise Announces Rescheduling of its Second Half and Fiscal Year End 2023 Earnings Conference Call (GlobeNewswire)
May-06-24 08:30AM Antelope Enterprise Schedules Second Half and Fiscal Year End 2023 Earnings Conference Call (GlobeNewswire)
Apr-29-24 09:00AM Antelope Enterprise Announces its Plan to Launch Energy Transmission Business and Appoints Management Team to Spearhead Such Initiative (GlobeNewswire)
Apr-01-24 08:30AM Antelope Enterprise Announces Preliminary Full Year 2023 Revenue of $70.4 Million, a Projected 65% Year-Over-Year Increase (GlobeNewswire) +5.81%
Feb-26-24 09:00AM Antelope Enterprise Announces Closing of $1.3 Million Registered Direct Offering and Private Placement (PR Newswire) -19.87%
Feb-21-24 04:15PM Antelope Enterprise Announces Warrant Exchange Agreements (PR Newswire)
Dec-01-23 08:00AM Antelope Enterprise Announces Changes to its Board of Directors (PR Newswire) +5.33%
Oct-04-23 09:30AM Antelope Enterprise Holdings Regains Compliance with NASDAQ Minimum Bid Price Requirement (PR Newswire)
APDN - Applied Dna Sciences Inc - Stock Price Chart
TickerAPDN [NASD]
CompanyApplied Dna Sciences Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap2.97MEPS (ttm)-17.21
P/E-EPS this Y14.47%
Forward P/E-EPS next Y18.46%
PEG-EPS past 5Y45.52%
P/S0.33EPS next 5Y-
P/B0.56EPS Q/Q70.94%
Dividend-Sales Q/Q-83.07%
Insider Own12.32%Inst Own16.23%
Insider Trans0.00%Inst Trans-
Short Float4.18%EarningsFeb 08/a
Analyst Recom1.00Target Price45.00
Avg Volume27.66K52W Range3.27 - 37.20
May-10-24 08:53PM APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace) -7.75%
05:15PM Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results (ACCESSWIRE)
09:00AM Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement (ACCESSWIRE)
May-09-24 05:21AM Xinjiang cotton widespread despite US UFLPA legislation (Just Style)
May-07-24 12:22PM Banned Chinese cotton found in 19% of US and global retailers' merchandise, study shows (Reuters)
12:17PM CORRECTED-Banned Chinese cotton found in 19% of US and global retailers' merchandise, study shows (Reuters)
Apr-25-24 09:00AM Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program (ACCESSWIRE)
Apr-22-24 04:05PM Applied DNA Announces 1-For-20 Reverse Stock Split (ACCESSWIRE)
Mar-18-24 09:00AM Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start (ACCESSWIRE) +19.57%
IOBT - IO Biotech Inc - Stock Price Chart
TickerIOBT [NASD]
CompanyIO Biotech Inc
CountryDenmark
IndustryBiotechnology
Market Cap94.21MEPS (ttm)-2.16
P/E-EPS this Y31.82%
Forward P/E-EPS next Y3.56%
PEG-EPS past 5Y-46.06%
P/S-EPS next 5Y-
P/B0.71EPS Q/Q42.94%
Dividend-Sales Q/Q-
Insider Own37.24%Inst Own46.93%
Insider Trans-2.58%Inst Trans-0.22%
Short Float0.10%EarningsMar 05/a
Analyst Recom1.33Target Price8.00
Avg Volume123.56K52W Range0.82 - 2.28
Apr-24-24 04:30PM IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Apr-15-24 08:30AM IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness (GlobeNewswire)
Apr-09-24 12:00PM IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103 (GlobeNewswire)
Apr-05-24 08:30AM IO Biotech Appoints Faical Miyara, Ph.D., as Chief Business Officer (GlobeNewswire)
08:30AM IO Biotech Appoints Fai al Miyara, Ph.D., as Chief Business Officer (GlobeNewswire)
Mar-07-24 02:01PM IO Biotech Inc (IOBT) Reports Year-End Financial Results and Progress in Clinical Trials (GuruFocus.com) +6.63%
Mar-06-24 04:11PM IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire)
Mar-05-24 10:52PM IOBT Stock Earnings: IO Biotech Misses EPS for Q4 2023 (InvestorPlace)
04:40PM IO Biotech Announces 2023 Fourth-Quarter and Year-End Results (GlobeNewswire)
Feb-26-24 04:05PM IO Biotech to Present at 44th Annual Cowen Health Care Conference (GlobeNewswire)
RNAZ - TransCode Therapeutics Inc - Stock Price Chart
TickerRNAZ [NASD]
CompanyTransCode Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap9.26MEPS (ttm)-472.87
P/E-EPS this Y97.93%
Forward P/E-EPS next Y68.69%
PEG-EPS past 5Y-28.81%
P/S-EPS next 5Y-
P/B0.54EPS Q/Q97.94%
Dividend-Sales Q/Q-
Insider Own0.53%Inst Own0.24%
Insider Trans0.00%Inst Trans-2.12%
Short Float2.29%EarningsApr 01/b
Analyst Recom1.00Target Price3.00
Avg Volume668.38K52W Range0.42 - 309.60
Apr-15-24 09:00AM TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors (GlobeNewswire) -13.68%
Apr-03-24 09:10AM TransCode Therapeutics Reports 2023 Results; Provides Business Update (GlobeNewswire)
Mar-28-24 08:30AM TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer (GlobeNewswire)
Mar-11-24 09:00AM TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment (GlobeNewswire) -8.60%
Mar-06-24 04:15PM TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress (GlobeNewswire)
Feb-20-24 08:00AM TransCode Therapeutics Reports Publication of United States Patent Application Covering TransCode's RIG-I Agonist Immunotherapeutic (GlobeNewswire)
Jan-31-24 04:05PM Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders' Equity Requirement and Continued Listing on The Nasdaq Stock Market (GlobeNewswire) -7.25%
Jan-29-24 08:30AM TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer (GlobeNewswire)
Jan-22-24 04:45PM TransCode Therapeutics Announces Closing of $7.25 Million Public Offering (GlobeNewswire)
Jan-19-24 01:09PM TransCode (RNAZ) Down 50% on Issue of New Common Stock (Zacks) -25.22%
123456⋯10⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.